Viewing Study NCT01610492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-26 @ 3:22 PM
Study NCT ID: NCT01610492
Status: COMPLETED
Last Update Posted: 2017-10-13
First Post: 2012-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glomerulonephritis, Membranous View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IMGN View
None anti-PLA2R antibodies View
None pharmacokinetics View
None belimumab View
None Benlysta View
None Idiopathic Membranous Glomerulonephropathy View
None safety View
None GSK1550188 View
None Lymphostat-B View
None membrane attack complex View